Skip to content
Surf Wiki
Save to docs
general/cancer-screening

From Surf Wiki (app.surf) — the open knowledge base

M2-PK Test

Screening for colorectal cancers and polyps


Screening for colorectal cancers and polyps

FieldValue
nameM2-PK Test
imageFile:Beispielbild M2-PK.JPG
captionM2-PK
purposefor early detection of colorectal cancers
DiseasesDB
ICD10
MedlinePlus
eMedicine
OPS301
LOINC

The M2-PK Test is a non-invasive screening method for the early detection of colorectal cancers and polyps which are known to be the precursors of colorectal cancer. The M2-PK Test which is used for stool analysis is available either as fully quantitative ELISA Test or as a rapid test that can be performed by any general practitioner without the need of a laboratory or any additional equipment.

The enzyme biomarker M2-PK has been identified as a key enzyme in colorectal cancers and polyps. The detection of M2-PK does not depend on blood in the stool and is specifically related on changes in the tumor metabolism. False positive results by unspecific blood sources in the bowel are excluded and the test is able to detect both bleeding as well as non-bleeding colorectal cancers and polyps. The M2-PK Test is able to detect 80.3% of colorectal cancers. Testing for M2-PK allows for colorectal cancer screening in asymptomatic patients. An elevated concentration of M2-PK in the stool should always be clarified by undergoing colonoscopy.

The gold standard of early detection of colon polyp/cancer is the invasive colonoscopy, but with high expense about $557, while tumor marker M2-PK Test expense only about $15-$25. The invasive colonoscopy makes acceptance of it low among patients, so relatively cheap non-invasive M2-PK Test is a good choice for detection early polyp/cancer.

References

References

  1. Tonus C., Sellinger M.. (August 2012). "Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis". World Journal of Gastroenterology.
  2. Carolin Tonus, Markus Sellinger, Konrad Koss, and Gero Neupert. (August 14, 2012). "Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis". World Journal of Gastroenterology.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about M2-PK Test — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report